Search
for
Sort by
Research 541–570 of 1000+
- An Unusual Presentation of Massive Asymptomatic Urinary Retention in a 63-Year-Old Male With Iron Deficiency Anaemia
- Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata
- P0881 Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis
- Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
- Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
- A stretchable wireless wearable bioelectronic system for multiplexed monitoring and combination treatment of infected chronic wounds
- Lef1 Contributes to the Differentiation of Bulge Stem Cells by Nuclear Translocation and Cross-Talk with the Notch Signaling Pathway
- Ceramide Synthase 4 Regulates Stem Cell Homeostasis and Hair Follicle Cycling
- Disruption of Smad4 in Mouse Epidermis Leads to Depletion of Follicle Stem Cells
- Scanning electron microscopy study of hair shaft changes related to hardness of water
- Highlights from the Field of Pediatric Dermatology Research from the 2023 PeDRA Annual Conference
- Post-Finasteride Syndrome (PFS) Update: Point/Counterpoint
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Late-Onset Systemic Lupus Erythematosus
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Immunosuppressive treatment for proliferative lupus nephritis
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Epitestosterone
- New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
- Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage
- IL-3 contributes to development of lupus nephritis in MRL/Ipr mice
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Acute liver damage due to <i>Serenoa repens</i>: a case report